C. Christopoulos et al., THE PLACE OF MYELOID GROWTH-FACTORS IN THE TREATMENT OF HAIRY-CELL LEUKEMIA, Clinical and laboratory haematology, 19(2), 1997, pp. 149-150
A patient with hairy-cell leukaemia was treated with granulocyte colon
y stimulating factor lenograstim (Granocyte) 300 mu g daily by subcuta
neous injections, His pre-existing neutropenia remitted and the therap
y was continued for a total of 4 months. When the therapy was disconti
nued the neutropenia returned. There was no evidence that the growth f
actor itself had any disease modifying activity.